Related Experiment Video
Updated: Jan 29, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
MicroRNA-374b accelerates the development of lung cancer through downregulating PTEN expression via activating
1Department of Thoracic Surgery, Qianshan hospital, Anshan, China. hanyeecn@163.com.
Objective:
To elucidate whether microRNA-374b could participate in the development of lung cancer (LC) through downregulating PTEN (gene of phosphate and tensin homolog deleted on chromosome ten) expression via activating PI3K/Akt pathway.
Patients And Methods:
Expression levels of microRNA-374b and PTEN in LC tissues and adjacent normal tissues were detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Moreover, the expression level of microRNA-374b in LC cell lines was detected as well. The microRNA-374b inhibitor was constructed and transfected to downregulate microRNA-374b expression in A549 and H358 cells. The regulatory effects of microRNA-374b on migratory and proliferative capacities of LC cells were explored by wound healing and cell counting kit-8 (CCK-8) assay, respectively. After co-transfection of microRNA-374b inhibitor and si-PTEN in LC cells, expression levels of PTEN/PI3K/Akt were determined by qRT-PCR and Western blot.
Results:
QRT-PCR results showed that microRNA-374b expression was higher, while PTEN expression was lower in LC tissues than adjacent tissues. Identically, microRNA-374b was also highly expressed in LC cell lines. PTEN expression was negatively correlated with microRNA-374b expression in LC. The downregulation of microRNA-374b in A549 and H358 cells inhibited their migratory and proliferative potentials. Subsequently, we verified that microRNA-374b could bind to PTEN through dual-luciferase reporter gene assay. MicroRNA-374b could inhibit PTEN expression and activate the PI3K/Akt pathway. Furthermore, PTEN knockdown enhanced migratory and proliferative abilities of LC cells, which were attenuated by co-transfection of microRNA-374b inhibitor.
Conclusions:
MicroRNA-374b promotes the development of LC by downregulating PTEN expression through activating PI3K/Akt pathway.
Insights
MicroRNA-374b promotes lung cancer (LC) by downregulating PTEN expression, activating the PI3K/Akt pathway. Inhibiting microRNA-374b reduces LC cell migration and proliferation.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Lung cancer (LC) is a leading cause of cancer mortality.
- MicroRNAs play crucial roles in cancer development.
- The specific role of microRNA-374b in LC requires further elucidation.
Purpose of the Study:
- To investigate the role of microRNA-374b in lung cancer development.
- To determine if microRNA-374b targets PTEN (gene of phosphate and tensin homolog deleted on chromosome ten).
- To explore the involvement of the PI3K/Akt pathway in microRNA-374b-mediated lung cancer progression.
Main Methods:
- Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) to measure microRNA-374b and PTEN expression.
- Cell culture and transfection with microRNA-374b inhibitors in LC cell lines (A549, H358).
- Wound healing and CCK-8 assays to assess cell migration and proliferation.
- Dual-luciferase reporter gene assay to confirm microRNA-374b binding to PTEN.
- Western blot to analyze protein expression in the PTEN/PI3K/Akt pathway.
Main Results:
- MicroRNA-374b expression was significantly higher in LC tissues and cell lines compared to normal tissues.
- PTEN expression was inversely correlated with microRNA-374b levels in LC.
- Downregulation of microRNA-374b inhibited migration and proliferation of LC cells.
- MicroRNA-374b directly targets PTEN, inhibiting its expression and activating the PI3K/Akt pathway.
- PTEN knockdown promoted LC cell migration and proliferation, effects attenuated by microRNA-374b inhibition.
Conclusions:
- MicroRNA-374b promotes lung cancer development.
- This promotion occurs via the downregulation of PTEN expression.
- Activation of the PI3K/Akt pathway is a key mechanism in microRNA-374b-driven lung cancer progression.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Accelerators
The effectiveness of calcium chloride can...
Lung Capacity

